Accumulating evidence has shown that prostaglandin E2 (PGE2), the main product of cyclooxygenase-2 (COX-2) activity, can promote a number of molecular mechanisms involved in colorectal carcinogenesis [20] in particular tumor cell proliferation and angiogenesis [21–24]. The gene discussed is PTGS2; the disease is medical procedure.